The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale

The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale

Abstract Background Iron deficiency anemia (IDA) is a common manifestation of chronic kidney disease (CKD), affecting most patients on hemodialysis and imposing a substantial clinical burden. Treatment with iron supplementation increases hemoglobin levels and can reduce the severity of anemia in pat...

Full description

Bibliographic Details
Main Authors: Iain C. Macdougall, Naomi V. Dahl, Kristine Bernard, Zhu Li, Alka Batycky, William E. Strauss
Format: Article
Language:English
Published: BMC 2017-04-01
Series:BMC Nephrology
Subjects:
Chronic kidney disease
Ferumoxytol
Hemodialysis
Iron overload
Iron sucrose
Oxidative stress
Online Access:http://link.springer.com/article/10.1186/s12882-017-0523-8

Internet

http://link.springer.com/article/10.1186/s12882-017-0523-8

Similar Items